Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01952548 · ClinicalTrials.gov registry record · Phase 1

Study Comparing the Pharmacokinetics, Pharmacodynamics, and Safety of K-312 in Healthy Adult Volunteers

A Phase 1 study, sponsored by Kowa Research Institute.

Completed
Registry status
Phase 1
Development phase

NCT01952548: Completed Phase 1 study, sponsored by Kowa Research Institute.

NCT01952548 is a Phase 1 study that has completed, run by Kowa Research Institute. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01952548, a Phase 1 study, has completed, sponsored by Kowa Research Institute.

COMPLETED
Registry status
Phase 1
Development phase

Study Summary

This study will test single doses of the study drug in increasing amounts to see if it is safe.

Interventions

  • DRUG Placebo
  • DRUG K-312

Trial Details

FieldValue
Start Date 2013-05
Phase Phase 1
Kowa Research Institute

44 total trials

What the finished NCT01952548 record still lists

NCT01952548 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.

The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.

NCT01952548 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01952548 about?

NCT01952548 is a clinical study titled "Study Comparing the Pharmacokinetics, Pharmacodynamics, and Safety of K-312 in Healthy Adult Volunteers". This study will test single doses of the study drug in increasing amounts to see if it is safe.

What is the current status of trial NCT01952548?

This trial is currently completed. It is a Phase 1 study. The study started on 2013-05.

What interventions are being tested in trial NCT01952548?

The interventions under investigation include: Placebo (DRUG), K-312 (DRUG).

Who is sponsoring clinical trial NCT01952548?

This trial is sponsored by Kowa Research Institute, which has 44 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01952548, the US trial registry maintained by the National Library of Medicine. NCT01952548 (unsized enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.